Hemostemix Inc.
HEM.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -62.79% | -78.74% | 391.03% | 31.17% | 201.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.63% | 128.95% | 536.39% | 31.93% | 199.21% |
| Operating Income | 35.63% | -128.95% | -536.39% | -31.93% | -199.21% |
| Income Before Tax | 36.53% | -101.42% | -56.72% | 41.40% | -153.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.53% | -101.42% | -56.72% | 41.40% | -153.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.53% | -101.42% | -56.72% | 41.40% | -153.79% |
| EBIT | 35.63% | -128.95% | -536.39% | -31.93% | -199.21% |
| EBITDA | 35.63% | -128.93% | -536.39% | -31.93% | -199.21% |
| EPS Basic | 62.77% | -8.86% | 3.85% | 65.91% | -135.00% |
| Normalized Basic EPS | 57.63% | -32.65% | -170.59% | 66.67% | -136.00% |
| EPS Diluted | 62.77% | -8.86% | 3.85% | 65.91% | -135.00% |
| Normalized Diluted EPS | 57.63% | -32.65% | -170.59% | 66.67% | -136.00% |
| Average Basic Shares Outstanding | 71.93% | 83.23% | 68.12% | 68.12% | 9.11% |
| Average Diluted Shares Outstanding | 71.93% | 83.23% | 68.12% | 68.12% | 9.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |